-
1.发明公开NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 有权CONNECTIONS XANTHINOXIDASEHEMMENDER效果，工艺因为，为了产生与药物组合物
公开(公告)号：EP2467378A2
公开(公告)日：2012-06-27
申请号：EP10822213.4
申请日：2010-10-04
申请人： LG Life Sciences Ltd
发明人： SONG, Jeong Uk , KIM, Geun Tae , CHOI, Sung Pil , JUNG, Cheol Kyu , PARK, Deok Seong , CHOI, Eun Sil , KIM, Tae Hun , PARK, Hyun Jung , PARK, Wan Su , PARK, Heui Sul , KOO, Ki Chul , ARTEMOV, Vasily
IPC分类号： C07D403/02 , C07D209/04 , A61K31/40 , A61P3/10
CPC分类号： C07D403/04 , C07D401/04 , C07D405/14 , C07D409/04
摘要： The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.
-
2.发明授权COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 有权CONNECTIONS XANTHINOXIDASEHEMMENDER效果，工艺因为，为了产生与药物组合物
公开(公告)号：EP2467378B1
公开(公告)日：2016-07-27
申请号：EP10822213.4
申请日：2010-10-04
申请人： LG Life Sciences Ltd
发明人： SONG, Jeong Uk , KIM, Geun Tae , CHOI, Sung Pil , JUNG, Cheol Kyu , PARK, Deok Seong , CHOI, Eun Sil , KIM, Tae Hun , PARK, Hyun Jung , PARK, Wan Su , PARK, Heui Sul , KOO, Ki Chul , ARTEMOV, Vasily
IPC分类号： C07D403/04 , C07D209/04 , A61K31/40 , A61P3/10 , C07D401/04 , C07D405/14 , C07D409/04
CPC分类号： C07D403/04 , C07D401/04 , C07D405/14 , C07D409/04
-
3.发明公开COMPLEX PREPARATION INCLUDING VALSARTAN AND ROSUVASTATIN CALCIUM AND MANUFACTURING METHOD THEREFOR 审中-公开根据上述制造缬沙坦和瑞舒伐他汀钙和工艺复合制剂
公开(公告)号：EP2977048A1
公开(公告)日：2016-01-27
申请号：EP14764870.3
申请日：2014-03-11
发明人： SONG, Jeong Uk , KIM, Geun Tae , KIM, Sun Il , LEE, Ki Kon
IPC分类号： A61K31/41 , A61K31/505 , A61P3/06 , A61P3/00
CPC分类号： A61K31/505 , A61K9/2086 , A61K9/209 , A61K31/41 , A61K2300/00
摘要： The present invention relates to a pharmaceutical composition including valsartan and rosuvastatin calcium as active ingredients, and a manufacturing method therefor. The pharmaceutical composition including valsartan and rosuvastatin calcium according to the present invention can alleviate side effects of the existing single preparations and simultaneously improve compliance of patients having a cardiovascular disease, a hyperlipidemic disease and a complex disease thereof, and increases treatment and prevention effects, and in particular, obtains synergistic effects in treating hyperlipidemia, and enhances the dissolution rate of valsartan and rosuvastatin calcium and treatment effects by granulating valsartan and mixing rosuvastatin calcium.
-
-
搜索结果
3 条记录 (耗时 0.01 秒)
